Viagra Could Treat Childhood Muscular Dystrophy Heart Problems

A new study suggests that Viagra, a drug used to treat erectile dysfunction primarily among older men, may be a potential treatment for heart failure associated with a form of muscular dystrophy that is usually seen in 2 to 6 year old boys.

The current issue of Proceedings of the National Acadamy of Sciences contains a study involving mice with muscular dystrophy. Researchers found that the mice who were given Viagra showed improved heart performance. Although further research will be necessary, this may mean that one day Viagra could be used to treat heart muscle problems associated with muscular dystrophy.

Viagra (sildenafil citrate) was approved in 1998 and is manufactured by Pfizer. Some of the more serious side effects of Viagra include reports of sudden hearing loss or a vision problems that could develop within 48 hours of taking the drug. Pfizer currently faces a number of Viagra lawsuits which are being pursued by users of the drug who experienced vision or hearing problems.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

A new lawsuit against Roblox alleges that the platform’s inadequate safety measures enabled multiple sexual predators to exploit a five-year-old girl.
Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm.
Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety.